These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 21764651)
1. Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma. Teng BL; Hacker KE; Chen S; Means AR; Rathmell WK Mol Oncol; 2011 Oct; 5(5):465-74. PubMed ID: 21764651 [TBL] [Abstract][Full Text] [Related]
2. SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling. Lin YC; Lu LT; Chen HY; Duan X; Lin X; Feng XH; Tang MJ; Chen RH Cancer Res; 2014 Dec; 74(23):6935-46. PubMed ID: 25293974 [TBL] [Abstract][Full Text] [Related]
3. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. Ryo A; Liou YC; Lu KP; Wulf G J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275 [TBL] [Abstract][Full Text] [Related]
4. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Zheng H; You H; Zhou XZ; Murray SA; Uchida T; Wulf G; Gu L; Tang X; Lu KP; Xiao ZX Nature; 2002 Oct; 419(6909):849-53. PubMed ID: 12397361 [TBL] [Abstract][Full Text] [Related]
5. Targeting peptidyl-prolyl isomerase pin1 to inhibit tumor cell aggressiveness. Beretta GL; De Cesare M; Albano L; Magnifico A; Carenini N; Corna E; Perego P; Gatti L Tumori; 2016; 102(2):144-9. PubMed ID: 26917410 [TBL] [Abstract][Full Text] [Related]
6. PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin. Cheng CW; Chow AK; Pang R; Fok EW; Kwong YL; Tse E Am J Pathol; 2013 Mar; 182(3):765-75. PubMed ID: 23333752 [TBL] [Abstract][Full Text] [Related]
7. Destabilization of KLF10, a tumor suppressor, relies on thr93 phosphorylation and isomerase association. Hwang YC; Yang CH; Lin CH; Ch'ang HJ; Chang VHS; Yu WCY Biochim Biophys Acta; 2013 Dec; 1833(12):3035-3045. PubMed ID: 23994618 [TBL] [Abstract][Full Text] [Related]
8. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer. Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277 [TBL] [Abstract][Full Text] [Related]
9. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Zacchi P; Gostissa M; Uchida T; Salvagno C; Avolio F; Volinia S; Ronai Z; Blandino G; Schneider C; Del Sal G Nature; 2002 Oct; 419(6909):853-7. PubMed ID: 12397362 [TBL] [Abstract][Full Text] [Related]
10. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis. Nakatsu Y; Sakoda H; Kushiyama A; Zhang J; Ono H; Fujishiro M; Kikuchi T; Fukushima T; Yoneda M; Ohno H; Horike N; Kanna M; Tsuchiya Y; Kamata H; Nishimura F; Isobe T; Ogihara T; Katagiri H; Oka Y; Takahashi S; Kurihara H; Uchida T; Asano T J Biol Chem; 2011 Jun; 286(23):20812-22. PubMed ID: 21454638 [TBL] [Abstract][Full Text] [Related]
12. Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines. Kanaoka R; Kushiyama A; Seno Y; Nakatsu Y; Matsunaga Y; Fukushima T; Tsuchiya Y; Sakoda H; Fujishiro M; Yamamotoya T; Kamata H; Matsubara A; Asano T PLoS One; 2015; 10(6):e0127467. PubMed ID: 26039047 [TBL] [Abstract][Full Text] [Related]
13. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun. Cho JH; Chae JI; Shim JH Oncol Rep; 2017 Mar; 37(3):1865-1872. PubMed ID: 28184937 [TBL] [Abstract][Full Text] [Related]
14. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition. Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941 [TBL] [Abstract][Full Text] [Related]
15. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. Wulf GM; Liou YC; Ryo A; Lee SW; Lu KP J Biol Chem; 2002 Dec; 277(50):47976-9. PubMed ID: 12388558 [TBL] [Abstract][Full Text] [Related]
16. Prolyl isomerase Pin1 regulates transcription factor LSF (TFCP2) by facilitating dephosphorylation at two serine-proline motifs. Saxena UH; Owens L; Graham JR; Cooper GM; Hansen U J Biol Chem; 2010 Oct; 285(41):31139-47. PubMed ID: 20682773 [TBL] [Abstract][Full Text] [Related]
17. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability. Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306 [TBL] [Abstract][Full Text] [Related]
18. Dual Roles of Pin1 in Cancer Development and Progression. Han HJ; Choi BY; Surh YJ Curr Pharm Des; 2017 Nov; 23(29):4422-4425. PubMed ID: 28671058 [TBL] [Abstract][Full Text] [Related]
19. Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α. Rajbhandari P; Ozers MS; Solodin NM; Warren CL; Alarid ET J Biol Chem; 2015 May; 290(22):13749-62. PubMed ID: 25866209 [TBL] [Abstract][Full Text] [Related]
20. Recent advances of Pin1 inhibitors as potential anticancer agents. Bai Y; Yuan Z; Yuan S; He Z Bioorg Chem; 2024 Mar; 144():107171. PubMed ID: 38325131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]